SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001062993-19-002437
Filing Date
2019-05-29
Accepted
2019-05-29 13:33:13
Documents
1
Group Members
CTI LIFE SCIENCES FUND II, L.P.CTI LIFE SCIENCES FUND, L.P.CTI PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A sched13ga.htm SC 13G/A 76463
  Complete submission text file 0001062993-19-002437.txt   78170
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Subject) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89971 | Film No.: 19860891
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 PLACE VILLE - MARIE SUITE 1050 MONTREAL A8 H3B4S6
Business Address 1 PLACE VILLE - MARIE SUITE 1050 MONTREAL A8 H3B4S6 5147982333X229
CTI Partners, L.P. (Filed by) CIK: 0001747233 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G/A